Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Correction: AstraZeneca Says Data Shows One Dose of COVID-19 Jab 'Highly Effective' Against Beta, Delta Variants

07/23/2021 | 05:06am EDT


© MT Newswires 2021
All news about ASTRAZENECA PLC
12:12pASTRAZENECA : Enhertu demonstrated clinically meaningful and durable response in..
PU
12:06pASTRAZENECA : ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated clinically..
BU
10:50aAstraZeneca Sees Positive Results for Enhertu Trial
DJ
10:09aLATEST : FDA panel to offer recommendations on booster shots
AQ
09:18aASTRAZENECA : EMA Fails To Find Link Between Blood Clots, AstraZeneca's Vaccine
MT
08:23aASTRAZENECA : Says Imfinzi-Oleclumab Combination Improved Clinical Outcomes for ..
MT
08:06aJOHNSON & JOHNSON : GSA Director Lauded for Luring More People to Get Covid-19 V..
AQ
07:31aASTRAZENECA : EU unsure if women face higher risk of clots from AstraZeneca shot
RE
07:31aASTRAZENECA : IMFINZI Combined With Novel Immunotherapies Improved Clinical Outc..
BU
07:11aASTRAZENECA : Buy rating from Morgan Stanley
MD
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 214 M - -
Net income 2021 4 990 M - -
Net Debt 2021 24 654 M - -
P/E ratio 2021 31,5x
Yield 2021 2,51%
Capitalization 172 B 172 B -
EV / Sales 2021 5,59x
EV / Sales 2022 4,52x
Nbr of Employees 76 100
Free-Float 96,3%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 112,31 $
Average target price 136,08 $
Spread / Average Target 21,2%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC11.16%173 735
JOHNSON & JOHNSON4.98%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.21.62%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.84%209 456